Literature DB >> 9788001

Predictors of dropout from psychosocial treatment of cocaine dependence.

L Siqueland1, P Crits-Christoph, A Frank, D Daley, R Weiss, J Chittams, J Blaine, L Luborsky.   

Abstract

The current study assessed demographic, drug and psychiatric predictors of dropout in the pilot/training phase of a large, multi-site psychotherapy outcome study for patients with cocaine dependence. The different predictors of dropout were assessed throughout the phases of the study: screening, intake, stabilization and assessment phase, and following randomization to treatment. Results showed that (1) younger patients were less likely to keep their intake appointment. (2) Of the patients who had an intake visit, those who did not complete high school and with more days of cocaine use in the previous month were less likely to complete an initial stabilization and assessment phase requiring 1 week of abstinence from all drugs. A survival analysis was used to examine time to dropout for the 286 patients randomized to individual treatment. (3) Again, younger age was associated with dropout after randomization. (4) Drug use variables did not predict time to dropout. (5) Presence of any current Axis I disorder was associated with later dropout from treatment. Minority treatment information seekers and treatment initiators were less likely to go on to complete the full treatment program.

Entities:  

Mesh:

Year:  1998        PMID: 9788001     DOI: 10.1016/s0376-8716(98)00039-8

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  14 in total

1.  When should we delay highly active antiretroviral therapy?

Authors:  D R Bangsberg; A Moss
Journal:  J Gen Intern Med       Date:  1999-07       Impact factor: 5.128

Review 2.  Illusory predictors: Generalizability of findings in cocaine treatment retention research.

Authors:  Angela L Stotts; Marc E Mooney; Shelly L Sayre; Meredith Novy; Joy M Schmitz; John Grabowski
Journal:  Addict Behav       Date:  2007-05-03       Impact factor: 3.913

3.  Predictors of treatment retention for substance-dependent adults with co-occurring depression.

Authors:  Susan R Tate; Jennifer Mrnak-Meyer; Chris L Shriver; Joseph H Atkinson; Shannon K Robinson; Sandra A Brown
Journal:  Am J Addict       Date:  2011-05-31

4.  Engagement and retention in outpatient alcoholism treatment for women.

Authors:  Fiona S Graff; Thomas J Morgan; Elizabeth E Epstein; Barbara S McCrady; Sharon M Cook; Noelle K Jensen; Shalonda Kelly
Journal:  Am J Addict       Date:  2009 Jul-Aug

5.  Predictors of dropout from group therapy among patients with bipolar and substance use disorders.

Authors:  Fiona S Graff; Margaret L Griffin; Roger D Weiss
Journal:  Drug Alcohol Depend       Date:  2007-12-26       Impact factor: 4.492

6.  Examining differential effects of psychosocial treatments for cocaine dependence: an application of latent trajectory analyses.

Authors:  Niklaus Stulz; Robert Gallop; Wolfgang Lutz; Glenda L Wrenn; Paul Crits-Christoph
Journal:  Drug Alcohol Depend       Date:  2009-09-25       Impact factor: 4.492

Review 7.  Psychosocial interventions for psychostimulant misuse.

Authors:  Silvia Minozzi; Rosella Saulle; Franco De Crescenzo; Laura Amato
Journal:  Cochrane Database Syst Rev       Date:  2016-09-29

8.  Client and program factors associated with dropout from court mandated drug treatment.

Authors:  Elizabeth Evans; Libo Li; Yih-Ing Hser
Journal:  Eval Program Plann       Date:  2008-12-11

9.  What could the program have done differently? A qualitative examination of reasons for leaving outpatient treatment.

Authors:  Alexandre B Laudet; Virginia Stanick; Brian Sands
Journal:  J Subst Abuse Treat       Date:  2009-03-31

10.  Poly-substance use and antisocial personality traits at admission predict cumulative retention in a buprenorphine programme with mandatory work and high compliance profile.

Authors:  Leif Öhlin; Morten Hesse; Mats Fridell; Per Tätting
Journal:  BMC Psychiatry       Date:  2011-05-12       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.